Will Trump nominate Balaji Srinivasan for FDA Commissioner?
ResolvedVolume
$39K
Txns
378
Traders
92
Fees
$0
Ends
Jun 30, 2025
Volume
$39K
Txns
378
Traders
92
Fees
$0
Ends
Jun 30, 2025
This market will resolve to "Yes" if Trump nominates Balaji Srinivasan, Jr. for Commissioner of Food and Drug Administration by June 30, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No". This market will resolve based on Trump's first nomination for this position - if Trump nominates another person to this position first, this market will immediately resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting may also be used.
Trades
| Age | Trader | Outcome | Shares | Value | |
|---|---|---|---|---|---|
| 1y | notebookled | Yes / 0.1¢ | -5.00 | $0.01 | |
| 1y | Evador | Yes / 0.1¢ | +5.00 | $0.01 | |
| 1y | Evador | Yes / 0.1¢ | +11.00 | $0.01 | |
| 1y | notebookled | Yes / 0.1¢ | -11.00 | $0.01 | |
| 1y | Evador | Yes / 0.1¢ | +2,037.00 | $2.04 | |
| 1y | Chutes | Yes / 0.1¢ | +1,145.00 | $1.15 | |
| 1y | Evador | Yes / 0.1¢ | +4,815.00 | $4.82 | |
| 1y | notebookled | Yes / 0.1¢ | +20.00 | $0.02 | |
| 1y | AIisTheNewWalkingDead | No / 99.9¢ | +8,017.00 | $8.01K | |
| 1y | Evador | Yes / 0.1¢ | +20.00 | $0.02 | |
| 1y | cigarettes | No / 99.9¢ | +20.00 | $20 | |
| 1y | notebookled | Yes / 0.1¢ | -20.00 | $0.02 | |
| 1y | Evador | Yes / 0.1¢ | +20.00 | $0.02 | |
| 1y | MMousse | No / 99.9¢ | +390.00 | $390 | |
| 1y | notebookled | Yes / 0.1¢ | +20.00 | $0.02 | |
| 1y | 3r3rsdfs | Yes / 0.1¢ | +350.00 | $0.35 | |
| 1y | asdasdasdasdasdasdasd | No / 99.9¢ | -20.00 | $20 | |
| 1y | MMousse | No / 99.7¢ | +20.00 | $19.9 | |
| 1y | Twizzler | Yes / 0.3¢ | +10.00 | $0.03 | |
| 1y | PolyDump | Yes / 0.3¢ | +10.00 | $0.03 | |
| 1y | cigarettes | No / 99.8¢ | +1,620.00 | $1.62K | |
| 1y | Iliilliill | Yes / 0.2¢ | +20.00 | $0.04 | |
| 1y | Evador | Yes / 0.2¢ | +1,600.00 | $3.2 | |
| 1y | MMousse | No / 99.7¢ | +250.00 | $249 | |
| 1y | daroghi | Yes / 0.3¢ | +250.00 | $0.75 |
1–25
FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
Yes 62%$4.12Kvolume
FDA approves Arcutis' Zoryve cream?
Yes 87%$4.03Kvolume
FDA approves Unicycive's Oxylanthanum carbonate?
Yes 78%$3.78Kvolume
FDA approves Retatrutide this year?
No 88%$414Kvolume
FDA approves Viridian Therapeutics' Veligrotug?
Yes 70%$3.05Kvolume
FDA approves Ionis' Olezarsen?
Yes 90%$2.4Kvolume